This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Prostate Disease  • Oncology  • Prostate Cancer  • Alert me on articles by topic

The Physician's Role in Clearing the Confusion

Timothy J. Wilt, MD, MPH

JAMA. 2000;283:3258-3260.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Early intervention for prostate cancer can theoretically cure a potentially disabling and deadly disease. However, evidence suggests that this approach may not improve survival and quality of life and may result in adverse effects. Therefore, men with clinically localized prostate cancer face difficult decisions regarding the management of their disease. To guide them in choosing between treatment options, patients seek information and recommendations from physicians.

The article by Fowler and colleagues¹ in this issue of THE JOURNAL suggests that urologists and radiation oncologists in the United States more commonly recommend interventions that they provide rather than accurately disseminating information about the uncertainty regarding the risks and benefits of early detection and treatment of prostate cancer. Based on a survey designed to assess clinicians' beliefs and practices regarding prostate cancer management, nearly all respondents recommended prostate-specific antigen (PSA) testing for men aged 50 to 74 years. . . . [Full Text of this Article]

Author Affiliation: Minneapolis VA Center for Chronic Disease Outcomes Research, Minneapolis, Minn.

RELATED ARTICLE

Comparison of Recommendations by Urologists and Radiation Oncologists for Treatment of Clinically Localized Prostate Cancer
Floyd J. Fowler, Jr, Mary McNaughton Collins, Peter C. Albertsen, Anthony Zietman, Diana B. Elliott, and Michael J. Barry
JAMA. 2000;283(24):3217-3222.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Who recommends long-term care matters.
Kane et al.
Gerontologist 2006;46:474-482.
ABSTRACT | FULL TEXT  

Liability for Failure to Order Screening Examinations
Berlin
Am. J. Roentgenol. 2002;179:1401-1405.
FULL TEXT  

Centrosome Defects Can Account for Cellular and Genetic Changes That Characterize Prostate Cancer Progression
Pihan et al.
Cancer Res. 2001;61:2212-2219.
ABSTRACT | FULL TEXT  

Quality of Evidence for Treatment of Prostate Cancer
Clarke and Wilt
JAMA 2000;284:1785-1786.
FULL TEXT